Abstract:Abstract Background The etiology of Alzheimer’s disease (AD) is currently unknown, but several risk factors have been associated with AD including infectious agents. The central nervous system (CNS) is continuously monitored by immune cells, many of which circulate through the cerebrospinal fluid and the meninges. Meningeal immune cells respond to CNS‐intrinsic perturbations, such as neuroinflammation or neurodegeneration as well as to CNS‐extrinsic challenges, such as systemic infection. The goal of the study is to analyze the profile of meningeal immune cells and T cell clonality in AD in comparison with other neurodegenerative diseases. Method We used single‐cell RNA and T‐cell receptor (TCR) sequencing to characterize CD45+ immune cells from fresh leptomeninges from AD, Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Result We identified multiple myeloid and lymphoid clusters in all neurodegenerative samples including meningeal macrophages expressing CD14 and C1QA and the resident meningeal macrophage marker LYVE‐1. Lymphoid populations represented the majority of total cells and were composed of both CD8+ effector memory T‐cells and a mixed population of NK cells and NK‐like T‐cells. Ligand/receptor network analyses identified several significant intercellular interactions including osteopontin signaling between meningeal macrophages and both clonally expanded cytotoxic CD8 T and NK/NK‐like T‐cells. TCR sequence analysis revealed up to 500 unique TCR clonotypes in each sample, many of which were hyperexpanded with 25‐50% of the TCR repertoire being occupied by the top 20 clonotypes and some of which had high TCRa chain sequence homology to EBV‐specific TCRs. Conclusion We provide evidence for disrupted myeloid homeostasis and broad T‐cell clonal expansion in the leptomeninges of AD patients. Network analyses suggest that meningeal macrophages in neurodegeneration may promote long‐term clonally expanded T‐cell survival through osteopontin signaling. These data recapitulate findings across several animal studies and will be useful in developing immunomodulatory interventions to treat neurodegeneration.

Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus

Neuroimmune Mechanisms Underlying Alzheimer's disease: Insights into central and peripheral immune cell crosstalk

Peripheral immune system in aging and Alzheimer’s disease

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease

Computational analysis of peripheral blood RNA sequencing data unravels disrupted immune patterns in Alzheimer's disease

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease

Neuroinflammation in Alzheimer's disease: insights from peripheral immune cells

The contribution of the peripheral immune system to neurodegeneration

The neuroimmune axis of Alzheimer's disease

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

Microglia in Alzheimer’s Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis

Mimicry of Central-Peripheral Immunity in Alzheimer's Disease and Discovery of Neurodegenerative Roles in Neutrophil

Common Peripheral Immunity Mechanisms in Multiple Sclerosis and Alzheimer's Disease

Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

Emerging microglial biology highlights potential therapeutic targets for Alzheimer's disease

CNS Immune Surveillance in Alzheimer’s Disease

Immune Activation in Alzheimer Disease

Peripheral and central regulation of neuro-immune crosstalk

Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival

Exploring the links among peripheral immunity, biomarkers, cognition, and neuroimaging in Alzheimer's disease

Cross-Talk of the CNS With Immune Cells and Functions in Health and Disease